Page last updated: 2024-11-02

phentermine and Chronic Disease

phentermine has been researched along with Chronic Disease in 5 studies

Phentermine: A central nervous system stimulant and sympathomimetic with actions and uses similar to those of DEXTROAMPHETAMINE. It has been used most frequently in the treatment of obesity.

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research Excerpts

ExcerptRelevanceReference
" In the late sixties, aminorex caused an epidemic of pulmonary hypertension with high mortality rates."4.80[Obesity: principles of drug therapy]. ( Ballmer, PE; Imoberdorf, R, 2000)
" Lorcaserin (Belviq(®)), phentermine/topiramate combination (Qsymia(®)), and bupropion/naltrexone combination have been demonstrated to be effective for the treatment of obesity, as an adjunct to a reduced-calorie diet and physical activity, although their absolute safety has yet to be established with more widespread use or longer use."3.79Therapies for obesity and medication-associated weight gain. ( Howland, RH, 2013)
"Obesity is a chronic disease requiring a similar long term approach to management as that of other chronic conditions."2.43Weight loss medications--where do they fit in? ( Dixon, JB, 2006)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Howland, RH1
Dixon, JB1
Brune, DB1
Cerda, JJ1
Imoberdorf, R1
Ballmer, PE1

Reviews

2 reviews available for phentermine and Chronic Disease

ArticleYear
Weight loss medications--where do they fit in?
    Australian family physician, 2006, Volume: 35, Issue:8

    Topics: Anti-Obesity Agents; Chronic Disease; Cyclobutanes; Diethylpropion; Humans; Lactones; Obesity; Orlis

2006
[Obesity: principles of drug therapy].
    Therapeutische Umschau. Revue therapeutique, 2000, Volume: 57, Issue:8

    Topics: Aminorex; Anti-Obesity Agents; Appetite Depressants; Chronic Disease; Combined Modality Therapy; Cyc

2000

Other Studies

3 other studies available for phentermine and Chronic Disease

ArticleYear
Therapies for obesity and medication-associated weight gain.
    Journal of psychosocial nursing and mental health services, 2013, Volume: 51, Issue:5

    Topics: Animals; Appetite Depressants; Bariatric Surgery; Benzazepines; Bupropion; Chronic Disease; Combined

2013
Anorectic medications in the treatment of obesity.
    Archives of family medicine, 1994, Volume: 3, Issue:2

    Topics: Appetite Depressants; Chronic Disease; Drug and Narcotic Control; Humans; Obesity; Ohio; Phentermine

1994
The pharmacologic management of obesity.
    The Journal of the Florida Medical Association, 1997, Volume: 84, Issue:2

    Topics: Adult; Anti-Obesity Agents; Appetite Depressants; Body Mass Index; Body Weight; Chronic Disease; Fen

1997